Skip to content
10-Q

Quarterly Report

SUTRO BIOPHARMA, INC. STRO

0001193125-25-270036

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 85.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 84.87M sh
Shares Diluted Q3 2025 · Sep 30, 2025 84.19M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.04M sh
Shares Diluted Q3 2025 · Sep 30, 2024 74.93M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$150.8M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$119.8M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $65.93M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $190.3M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $174.58M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$87.27M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$32.11M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$25.81M
Stockholders Equity Q3 2025 · Dec 31, 2024 $44.6M
Stockholders Equity Q3 2025 · Sep 30, 2024 $111.22M
Stockholders Equity Q3 2025 · Jun 30, 2024 $152.18M
Stockholders Equity Q3 2025 · Mar 31, 2024 $98.02M
Stockholders Equity Q3 2025 · Dec 31, 2023 $149.65M
Current Liabilities Q3 2025 · Sep 30, 2025 $71.9M
Current Liabilities Q3 2025 · Dec 31, 2024 $131.89M
Total Liabilities Q3 2025 · Sep 30, 2025 $296.93M
Total Liabilities Q3 2025 · Dec 31, 2024 $342.61M
Current Assets Q3 2025 · Sep 30, 2025 $182.11M
Current Assets Q3 2025 · Dec 31, 2024 $343.31M
Total Assets Q3 2025 · Sep 30, 2025 $209.66M
Total Assets Q3 2025 · Dec 31, 2024 $387.21M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.67
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.71
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.59
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.07
Eps Basic Q3 2025 · Sep 30, 2025 −$0.67
Eps Basic Q3 2025 · Sep 30, 2025 −$1.71
Eps Basic Q3 2025 · Sep 30, 2024 −$0.59
Eps Basic Q3 2025 · Sep 30, 2024 −$2.07
Sga Expense Q3 2025 · Sep 30, 2025 $8.74M
Sga Expense Q3 2025 · Sep 30, 2025 $32.36M
Sga Expense Q3 2025 · Sep 30, 2024 $14.33M
Sga Expense Q3 2025 · Sep 30, 2024 $39.42M
Rd Expense Q3 2025 · Sep 30, 2025 $39.85M
Rd Expense Q3 2025 · Sep 30, 2025 $129.78M
Rd Expense Q3 2025 · Sep 30, 2024 $62.11M
Rd Expense Q3 2025 · Sep 30, 2024 $181.01M
Net Income Q3 2025 · Sep 30, 2025 −$56.86M
Net Income Q3 2025 · Sep 30, 2025 −$144.32M
Net Income Q3 2025 · Jun 30, 2025 −$11.5M
Net Income Q3 2025 · Mar 31, 2025 −$75.97M
Net Income Q3 2025 · Sep 30, 2024 −$48.79M
Net Income Q3 2025 · Sep 30, 2024 −$155.02M
Net Income Q3 2025 · Jun 30, 2024 −$48.02M
Net Income Q3 2025 · Mar 31, 2024 −$58.21M
Operating Income Q3 2025 · Sep 30, 2025 −$48.46M
Operating Income Q3 2025 · Sep 30, 2025 −$120.32M
Operating Income Q3 2025 · Sep 30, 2024 −$67.92M
Operating Income Q3 2025 · Sep 30, 2024 −$173.2M
Revenue Q3 2025 · Sep 30, 2025 $9.69M
Revenue Q3 2025 · Sep 30, 2025 $90.84M
Revenue Q3 2025 · Sep 30, 2024 $8.52M
Revenue Q3 2025 · Sep 30, 2024 $47.23M